Vanguard Global Advisers
PAHC icon

Vanguard Global Advisers’s Phibro Animal Health PAHC Stock Holding History

Vanguard Global Advisers’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Hold
15,861
– – ﹤0.01% 2108
2026
Q1 		$877K Buy
+15,861
New +$755K ﹤0.01% 1726

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Global Advisers's PAHC Position: Q2 2026 in Review

Vanguard Global Advisers held its Phibro Animal Health (PAHC) position steady in Q2 2026 at 15,861 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

Vanguard Global Advisers first reported a position in PAHC in Q1 2026 and has held it in 2 quarters since. The position peaked at $877K in Q1 2026. 207 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Vanguard Global Advisers held 15,861 shares of Phibro Animal Health worth $498K as of Q2 2026.
  • Vanguard Global Advisers left its Phibro Animal Health share count unchanged in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2108 holding.
  • Vanguard Global Advisers first reported a position in Phibro Animal Health in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Phibro Animal Health position peaked at $877K in Q1 2026.
  • 207 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.